What happens after R1 resection in patients undergoing laparoscopic total mesorectal excision for rectal cancer? A study in 333 consecutive patients

Colorectal Disease

Volumn 17, Issue 3, 2015, Pages 197-204

  Debove, C ^a   Maggiori, L ^a   Chau, A ^a   Kanso, F ^a   Ferron, M ^a   Panis, Y ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Laparoscopy; Prognosis; R1 resection; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL LIVER METASTASIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HEART FAILURE; HUMAN; ILEOSTOMY; LAPAROSCOPIC SURGERY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OVARY METASTASIS; OVERALL SURVIVAL; PERITONEUM METASTASIS; PERITONITIS; PRIORITY JOURNAL; RECTUM CANCER; RECTUM RESECTION; RECURRENCE RISK; RESPIRATORY FAILURE; SURVIVAL RATE; ABDOMINAL SURGERY; LAPAROSCOPY; MESOCOLON; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; RECTAL NEOPLASMS; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LAPAROSCOPY; MALE; MESOCOLON; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84923053697     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12849     Document Type: Article

References (32)

1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg 1982; 69: 613-6.
2. Arbman G, Nilsson E, Hallbook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996; 83: 375-9.
3. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
4. Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-23.
5. Gerard JP, Conroy T, Bonnetain F et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Onco 2006; 24: 4620-5.
6. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 2008; 26: 303-12.
7. Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg 1983; 70: 150-4.
8. Adam IJ, Mohamdee MO, Martin IG et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344: 707-11.
9. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2: 996-9.
10. Caricato M, Borzomati D, Ausania F, Valeri S, Rosignoli A, Coppola R. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 2006; 32: 126-32.
11. Hall NR, Finan PJ, al-Jaberi T et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 1998; 41: 979-83.
12. Wibe A, Rendedal PR, Svensson E et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-34.
13. Gopall J, Shen XF, Cheng Y. Current status of laparoscopic total mesorectal excision. Am J Surg 2012; 203: 230-41.
14. Monson JR, Weiser MR, Buie WD, Chang GJ, Rafferty JF. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2013; 56: 535-50.
15. Bretagnol F, Panis Y, Rullier E et al. Rectal cancer surgery with or without bowel preparation: the French GRECCAR III multicenter single-blinded randomized trial. Ann Surg 2010; 252: 863-8.
16. Maggiori L, Bretagnol F, Aslam MI et al. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision? Surgery 2014; 155: 468-75.
17. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 2008; 26: 3517-22.
18. Washington MK, Berlin J, Branton P et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 2009; 133: 1539-51.
19. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. 6th edition. New York, NY: Wiley-Liss, 2002.
20. van Gijn W, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12: 575-82.
21. Kusters M, Marijnen CA, van de Velde CJ et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 2010; 36: 470-6.
22. Glimelius B, Tiret E, Cervantes A, Arnold D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): vi81-8.
23. van de Velde CJ, Boelens PG, Borras JM et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer 2014; 50: 1 e1-1 e34.
24. de Haas-Kock DF, Baeten CG, Jager JJ et al. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 1996; 83: 781-5.
25. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002; 26: 350-7.
26. Bretagnol F, Lelong B, Laurent C et al. The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma. Surg Endosc 2005; 19: 892-6.
27. Staudacher C, Di Palo S, Tamburini A, Vignali A, Orsenigo E. Total mesorectal excision (TME) with laparoscopic approach: 226 consecutive cases. Surg Oncol 2007; 16(Suppl 1): S113-6.
28. Ng KH, Ng DC, Cheung HY et al. Laparoscopic resection for rectal cancers: lessons learned from 579 cases. Ann Surg 2009; 249: 82-6.
29. Gosens MJ, Klaassen RA, Tan-Go I et al. Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 2007; 13: 6617-23.
30. Ding P, Liska D, Tang P et al. Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study. Ann Surg 2012; 256: 111-6.
31. Berge T, Ekelund G, Mellner C, Pihl B, Wenckert A. Carcinoma of the colon and rectum in a defined population. An epidemiological, clinical and postmortem investigation in colorectal carcinoma and coexisting benign polyps in Malmö, Sweden. Acta Chir Scand Suppl 1973; 438: 1-86.
32. Guillou PJ, Quirke P, Thorpe H et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005; 365: 1718-26.